Alternatively, among the 28 genes that were associated with a worse prognosis in GBM patients, the expressions of AEBP1, C1RL, CHL1, CHST2, EFEMP2, and PGCP were negatively related to the long-term survival of GBM patients. Here, CHL1 is linked to glioblastoma.